We already know the results of the eighth edition of the MINIATURA competition announced by the National Science Centre in Krakow. Among the prize-winners is Ms Amanda Bartkowiak, PhD, who will carry out a project entitled: “Do flozins improve erythrocyte nanomechanics? Investigation of the new flozin effect in patients with heart failure”.
We are happy to announce that on 27.09.2024, at the headquarters of the Ministry of Science and Higher Education, a contract for funding research teams within the framework of the Virtual Research Institute was signed for the project entitled: ‘Personalized endothelial diagnostics in anticancer treatment; towards modern vasculo-oncology’ [acronym: ADEVASCO (Aptamer-Based Diagnosis of Endothelium in Vasculooncology)]. The agreement was signed on the part of the Jagiellonian University by Prof Wojciech Macyk, UJ Vice-Chancellor for Science.
The leader of the research team is Prof. Stefan Chłopicki, PhD, Jagiellonian University, the project will be carried out in a consortium with five Polish research institutes (Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences in Wrocław, Institute of Animal Reproduction and Food Research Polish Academy of Sciences in Olsztyn, Medical University of Gdańsk, Maria Sklodowska-Curie National Research Institute of Oncology in Gliwice and Warsaw University of Technology). The key project team includes: Prof Szczepan Zapotoczny, PhD / Jagellonian University, Prof Joanna Wietrzyk, PhD / Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences, Iwona Grabowska, PhD / Institute of Animal Reproduction and Food Research Polish Academy of Sciences, Prof Michał J. Markuszewski, PhD / Medical University of Gdańsk, Prof Ryszard T. Smoleński, PhD / Medical University of Gdańsk, Mateusz Tajstra, PhD / National Research Institute of Oncology, Prof Mariusz Pietrzak, PhD / Warsaw University of Technology.
(more…)We are pleased to invite you to the next conference in the series ‘Krakow Conference on Endothelium’, which will take place on 25 – 27 September 2024 in Krakow. The series of conferences on pharmacology of endothelium – recently named, Krakow Conference on Endothelium – was initiated by Prof. Ryszard Gryglewski and subsequently organized by Prof. Stefan Chłopicki. This year will be the 29th conference organized jointly by Prof. Stefan Chłopicki (JCET – Krakow, Poland), Prof. Gabor Csanyi (VBC – Augusta University, USA), Prof. Tilman Hackeng (CARIM – Maastricht, the Netherlands) and Prof. Vicente Andrés, CNIC (Madrid, Spain), covering topics related to endothelial and vascular biomedicine (flyer of the conference).
The conference programe includes 4 main lectures, over 40 presentations, almost half of which will be short presentations, some of which will be selected from submitted abstracts (book of abstracts). As usual, the conference will include one-minute presentations of all posters. This scheme has worked well at our previous conferences and usually includes around 60-80 poster presentations. The best of these are awarded prizes.
So, join us with your colleagues for our 29th Krakow Conference on Endothelium 2024.
We would like to officially welcome a new member of the JCET team, Aneta Radziwon-Balicka, Ph.D., who will be carrying out a project entitled: “Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier integrity“, under funding from the POLONEZ BIS-3 programme.
POLONEZ BIS is co-funded by the European Commission and the Polish National Science Centre under the Marie Skłodowska-Curie COFUND grant. In three calls, the programme recruited over 120 experienced researchers from all over the world. They will move to Poland for 24 months to conduct their basic research in public or private institutions of their choice.
